3Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol,2002,15 (4) :397-405.
5Werling RW, Hwang H, Ysziji H, et al. Immunohistochemical dis- tinction of invasive from noninvasive breast lesions. Am J Surg Patho1,2003,27 ( 1 ) :82-90.
6[1]Nayar R, Breland C, Bedrossian U,et al. Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma. Ann Diagn Pathol, 1999,3(3): 165～73.
7[2]Wang X, Mori I, Tang W,et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer, 2002,9(3):216～9.
8[3]Werling RW, Hwang H, Yaziji H,et al. Immunohistochemical distinction of invasive from noninvasive breast lesions:A comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol, 2003,27(1):82～90.
9[4]Ribeiro-Silva A, Zamzelli Ramalho LN, Garcia SB, et al. Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast? Pathol Oncol Res, 2003,9(1): 20～3.
10Yoder B J, Wilkinson E J, Massoll NA. Molecular and morphologic distinctions between irdihrating ductal and lobular carcinoma of the breast [J]. Breast, 2007, 13 (2): 172.
